Afya Ltd: MEC Decides Medical Seat Numbers for 2025
Ticker: AFYA · Form: 6-K · Filed: Sep 6, 2024 · CIK: 1771007
| Field | Detail |
|---|---|
| Company | Afya LTD (AFYA) |
| Form Type | 6-K |
| Filed Date | Sep 6, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-update, education, enrollment
Related Tickers: AFYA
TL;DR
MEC finalized 2025 medical seats for Afya, impacting enrollment and revenue.
AI Summary
Afya Limited announced on September 6, 2024, that the MEC (Ministry of Education) has decided on the number of medical seats for the 2025 academic year. This decision is crucial for Afya's enrollment planning and revenue projections for its medical education courses.
Why It Matters
The MEC's decision directly impacts Afya's student enrollment capacity and future revenue, as it determines the number of available spots in their medical programs.
Risk Assessment
Risk Level: medium — The MEC's decisions on medical seats can significantly affect Afya's enrollment numbers and financial performance, introducing regulatory risk.
Key Players & Entities
- Afya Limited (company) — Registrant
- MEC (company) — Ministry of Education, decision maker
- 2025 (date) — Academic year for medical seats
- September 6, 2024 (date) — Filing date
FAQ
What was the specific decision made by the MEC regarding medical seats for Afya?
The filing states that the MEC has decided on the number of medical seats for the 2025 academic year, but the exact number is not detailed in this 6-K filing.
When was this announcement made by Afya Limited?
Afya Limited announced the MEC's decision on September 6, 2024.
What is the significance of the MEC's decision for Afya?
The MEC's decision is significant as it determines the number of medical seats available for enrollment, directly impacting Afya's student capacity and revenue potential for its medical education programs.
Does this filing provide the exact number of medical seats allocated by the MEC?
No, this 6-K filing announces that a decision has been made by the MEC regarding the number of medical seats for 2025, but it does not specify the exact quantity.
What form is this filing?
This filing is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Stats: 222 words · 1 min read · ~1 pages · Grade level 18.9 · Accepted 2024-09-06 08:46:10
Filing Documents
- afya20240906_6k.htm (6-K) — 12KB
- ex99-1.htm (EX-99.1) — 4KB
- afya202409066k_001.jpg (GRAPHIC) — 2KB
- 0001292814-24-003374.txt ( ) — 21KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2024 Commission File Number: 001 - 38992 Afya Limited (Exact name of registrant as specified in its charter) Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503 Vila da Serra, Nova Lima, Minas Gerais Brazil +55 (31) 3515 7550 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F X Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes No X Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes No X TABLE OF CONTENTS EXHIBIT 99.1 Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Afya Limited By: /s/ Virgilio Deloy Capobianco Gibbon Name: Virgilio Deloy Capobianco Gibbon Title: Chief Executive Officer Date: September 6, 2024